New psoriasis drug shows promise in Mid-Stage trial
Disease control
Recruiting now
This Phase 2 trial is testing a new biologic drug called HB0017 in 200 adults with moderate to severe plaque psoriasis. Participants receive different doses and schedules of the injection to see how well it clears skin plaques and how safe it is. The study is double-blind and ran…
Phase: PHASE2 • Sponsor: Huabo Biopharm Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC